Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Discover what to know about cash back and taxes to manage your finances better. Stay informed and make wise decisions.
28,655 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Dell Technologies grabbed headlines as its AI-focused strategy started to show momentum. This piece breaks down why d...
Disney is testing a bold move: a unified app that ties together its streaming, parks, and products. This article brea...
Dutch Bros has grown from a regional coffee shop to a national sensation. This article weighs the case for dutch bros...
Alaska Air Group stock surged this week as investors weighed fuel-cost pressures against resilient demand and discipl...
Teladoc has faced a challenging stretch after its pandemic boom. This guide examines whether teladoc stock going read...
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
Imagine income investments that don’t just pay a dividend, they propel total returns. This article highlights three d...
A prominent investment advisor just made a sizable play in a well-known theme park company. This article dives into t...
NVIDIA helped turn early bets into life-changing gains. But can it keep delivering millionaire-maker returns? This pr...
Two Harbors Investment Corp. says UWM Holdings failed to submit a revised bid or request more time as the negotiation...
A looked-at moment in media power and money: how a public challenge can ripple into legal fees, PR costs, and real-wo...